Methylation of the miR ‑29b‑3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer.

This study indicated that the alteration of methylation of mR‑19b may be a potential approach for inhibiting the progression of pancreatic cancer. PMID: 33416135 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33416135?dopt=Abstract

Source: Oncology Reports - January 10, 2021 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research